Northrop Grumman Corporation NOC
Composite 50/100; the shares have moved about 27% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 24/100 — a strong mark against it.
Quality ranks 61/100 — a slight point in its favour. Balance-sheet strength ranks 60/100 — a slight point in its favour. Income ranks 57/100 — a slight point in its favour.
Momentum ranks 24/100 — a strong mark against it. Valuation ranks 44/100 — a slight mark against it. Growth ranks 48/100 — a slight mark against it.
What the company does Northrop Grumman designs, develops, and produces aerospace and defense systems across Aeronautics, Defense, Mission, and Space segments, including strategic aircraft, missile defense, and autonomous systems.
Key financials Strong profitability with ROE 27%, ROA 7.1%, and net margin 10.5%. Revenue and EPS growth are modest at 2.2% and 2.6%, respectively. Leverage is moderate (Debt/Equity 0.95) with interest coverage 8.98x and current ratio 1.17.
Stock health Momentum is weak: -29.89% over 6 months, -9.67% over 12 months, and -31.72% below the 52-week high. RSI(14) at 36.80 indicates oversold conditions. Sideravia scores Quality 60.7 and Valuation 44.3, with Momentum at 23.7.
Price vs fair value The stock trades at a discount of 23.50% versus the analyst mean target of 647.14. - Recent $863M Army deal supports near-term revenue (IQIQ Army deal, 2026-09-03). - Comparative analysis pits Northrop against Kratos Defense (Better Drone Stock: Kratos Defense vs. Northrop Grumman, 2026-09-03). - Peer performance comparisons highlight relative valuation debates (Zacks Analyst Blog, 2026-09-01).
Looking forward Forward P/E of 18.83 suggests moderate earnings expectations. FCF yield of 3.3% and dividend yield of 1.9% provide income support, though payout ratio is 33.3%. Growth remains a key monitor given low revenue and EPS momentum.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.